Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-12

Clinical Trial Update: Gabapentin and Donepezil Combination on Experimental Human Pain Models [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a gabapentin and donepezil combination in experimental human pain models has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aricept (Donepezil)
  • NEURONTIN (gabapentin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pain, Neuropathic | Phase 1 | Status: COMPLETED